Kinesiophobia in Crohn's disease: A matched case-control study

Background Crohn’s disease (CD) is a long-term inflammatory condition and a chronic immune-mediated inflammatory disorder characterized by recurrent gastrointestinal symptoms and substantial physical and psychological burden. However, evidence regarding kinesiophobia in patients with CD remains scarce. Objectives To compare kinesiophobia levels between patients with CD and age-, sex-, and body mass index-matched healthy controls using the Spanish short version of the Tampa Scale of Kinesiophobia Spanish Version (TSK-11SV). Material and Methods A matched case-control study was conducted including 108 participants (54 patients with CD and 54 healthy controls). Demographic and anthropometric variables were collected, and all participants completed the TSK-11SV questionnaire. Group differences in continuous variables were analysed using appropriate inferential statistics after assessment of data distribution. Kinesiophobia severity categories were compared using Contingency tables and measures of association. Effect sizes were calculated to improve clinical interpretation of the findings. Results Patients with Crohn's disease presented significantly higher TSK-11SV scores than healthy controls (27.35 ± 6.19 vs. 23.39 ± 5.33 points, respectively). The mean difference was 3.96 points (p < 0.001), corresponding to a moderate effect size (Cohen's dz = 0.69). Moderate-to-extreme kinesiophobia was identified in 70.4% of patients with CD compared with 40.7% of healthy controls (p = 0.015). Extreme kinesiophobia was observed exclusively in the CD group. Conclusions Individuals with CD exhibit significantly greater fear of movement than healthy controls. These findings suggest that kinesiophobia may constitute an important psychological barrier to physical activity in CD and should be routinely considered during multidisciplinary disease management. Early identification of patients with elevated kinesiophobia may facilitate the implementation of individualized exercise-based interventions aimed at improving long-term physical and psychological outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Tissue Viability
Published
2026-07-27
DOI
https://doi.org/10.1016/j.jtv.2026.101036
Primary Topic
Therapeutic Uses of Natural Elements
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Kinesiophobia in Crohn's disease: A matched case-control study

Juan Camilo Gómez-Salgado, Ricardo Vallejo, Miguel Saavedra García, Ana María Jiménez‐Cebrián et al.
Journal of Tissue Viability
Therapeutic Uses of Natural Elements
article

Kinesiophobia in Crohn's disease: A matched case-control study

Juan Camilo Gómez-Salgado, Ricardo Vallejo, Miguel Saavedra García, Ana María Jiménez‐Cebrián, Daniel López‐López, Marta Elena Losa‐Iglesias, J Prados, Antonio Cortés-Rodríguez
article en

Abstract

Background Crohn’s disease (CD) is a long-term inflammatory condition and a chronic immune-mediated inflammatory disorder characterized by recurrent gastrointestinal symptoms and substantial physical and psychological burden. However, evidence regarding kinesiophobia in patients with CD remains scarce. Objectives To compare kinesiophobia levels between patients with CD and age-, sex-, and body mass index-matched healthy controls using the Spanish short version of the Tampa Scale of Kinesiophobia Spanish Version (TSK-11SV). Material and Methods A matched case-control study was conducted including 108 participants (54 patients with CD and 54 healthy controls). Demographic and anthropometric variables were collected, and all participants completed the TSK-11SV questionnaire. Group differences in continuous variables were analysed using appropriate inferential statistics after assessment of data distribution. Kinesiophobia severity categories were compared using Contingency tables and measures of association. Effect sizes were calculated to improve clinical interpretation of the findings. Results Patients with Crohn's disease presented significantly higher TSK-11SV scores than healthy controls (27.35 ± 6.19 vs. 23.39 ± 5.33 points, respectively). The mean difference was 3.96 points (p < 0.001), corresponding to a moderate effect size (Cohen's dz = 0.69). Moderate-to-extreme kinesiophobia was identified in 70.4% of patients with CD compared with 40.7% of healthy controls (p = 0.015). Extreme kinesiophobia was observed exclusively in the CD group. Conclusions Individuals with CD exhibit significantly greater fear of movement than healthy controls. These findings suggest that kinesiophobia may constitute an important psychological barrier to physical activity in CD and should be routinely considered during multidisciplinary disease management. Early identification of patients with elevated kinesiophobia may facilitate the implementation of individualized exercise-based interventions aimed at improving long-term physical and psychological outcomes.

Journal of Tissue ViabilityVol. 35(4)
Universidade da Coruña (ES), Universidad Complutense de Madrid (ES), Universidad Rey Juan Carlos (ES), Universidad Espíritu Santo (EC), Instituto de Investigación Biomédica de Málaga (ES), Universidad de Huelva (ES), Universidad de Málaga (ES)
Universidade da Coruña
Zero hunger
Openalex Percentile: Top 6%
Therapeutic Uses of Natural Elements
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.